University of Groningen
Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
(vol 16, pg 133, 2018)
Peters, Michel L.; de Meijer, Claudine; Wyndaele, Dirk; Noordzij, Walter; Leliveld-Kors,
Annemarie M.; van den Bosch, Joan; van den Berg, Pieter H.; Baka, Agni; Gaultney, Jennifer
G.
Published in:
Applied Health Economics and Health Policy
DOI:
10.1007/s40258-017-0364-4
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2018
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Peters, M. L., de Meijer, C., Wyndaele, D., Noordzij, W., Leliveld-Kors, A. M., van den Bosch, J., van den
Berg, P. H., Baka, A., & Gaultney, J. G. (2018). Dutch Economic Value of Radium-223 in Metastatic
Castration-Resistant Prostate Cancer (vol 16, pg 133, 2018). Applied Health Economics and Health Policy,
16(1), 145. https://doi.org/10.1007/s40258-017-0364-4
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
C O R R E C T I O N
Correction to: Dutch Economic Value of Radium-223
in Metastatic Castration-Resistant Prostate Cancer
Michel L. Peters
1•Claudine de Meijer
2•Dirk Wyndaele
3•Walter Noordzij
4•Annemarie M. Leliveld-Kors
5•Joan van den Bosch
6•Pieter H. van den Berg
7•Agni Baka
1•Jennifer G. Gaultney
8Published online: 4 January 2018
Ó The Author(s) 2018. This article is an open access publication
Correction to: Appl Health Econ Health Policy
https://doi.org/0.1007/s40258-017-0350-x
The article Dutch Economic Value of Radium-223 in
Metastatic Castration-Resistant Prostate Cancer, written by
Michel L. Peters, Claudine de Meijer, Dirk Wyndaele,
Walter Noordzij, Annemarie M. Leliveld-Kors, Joan van
den Bosch, Pieter H. van den Berg, Agni Baka, Jennifer G.
Gaultney was originally published electronically on the
publisher’s internet portal (currently SpringerLink) on 2nd
September, 2017 without open access.
With the author(s)’ decision to opt for Open Choice the
copyright of the article changed on 24th November, 2017
to
Ó The Author(s) 2017 and the article is forthwith
dis-tributed under the terms of the Creative Commons
Attri-bution-NonCommercial 4.0 International License (
http://
creativecommons.org/licenses/by-nc/4.0/
), which permits
any noncommercial use, duplication, adaptation,
distribu-tion and reproducdistribu-tion in any medium or format, as long as
you give appropriate credit to the original author(s) and the
source, a link is provided to the Creative Commons license
and any changes made are indicated. The original article
was corrected.
Compliance with Ethical Standards Funding Open Access was funded by Bayer.
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
The original article can be found online athttps://doi.org/10.1007/ s40258-017-0350-x.
& Jennifer G. Gaultney jgaultney@mapigroup.com
1 Real World Strategy and Analytics, Mapi Group, Houten,
The Netherlands
2 Bayer B.V., Mijdrecht, The Netherlands
3 Department of Nuclear Medicine, Catharina Ziekenhuis,
Eindhoven, The Netherlands
4 Department of Nuclear Medicine and Molecular Imaging,
University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
5 Department of Urology, University of Groningen, University
Medical Centre Groningen, Groningen, The Netherlands
6 Department of Internal Medicine, Albert Schweitzer
Ziekenhuis, Dordrecht, The Netherlands
7 Department of Internal Medicine, Tergooi Ziekenhuizen,
Hilversum, The Netherlands
8 Real World Strategy and Analytics, Mapi Group, The
Translation and Innovation Hub Building, 5th Floor, 80 Wood Lane, White City, London W12 OBZ, UK Appl Health Econ Health Policy (2018) 16:145 https://doi.org/10.1007/s40258-017-0364-4
